Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial
2025 · Nature Cancer · 36 citations
https://doi.org/10.1038/s43018-025-00921-6
S
Shuhua Yi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
556
Papers
2.0K
Citations
25
h-index
60
i10-index
Shuhua Yi is an academic researcher from Southwest General Health Center. The author has contributed to research in topics: Chronic Lymphocytic Leukemia Research & Lymphoma Diagnosis and Treatment & Multiple Myeloma Research and Treatments. The author has an h-index of 25, co-authored 473 publications.
ORCID: 0000-0002-6291-812XPapers by this author
worksPOEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis
2021 · Clinical Lymphoma Myeloma & Leukemia · 20 citations
https://doi.org/10.1016/j.clml.2021.10.007
BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phase
2017 · BMC Medical Genetics · 14 citations
https://doi.org/10.1186/s12881-017-0381-z
Physical activity and sleep quality among pregnant women during the first and second trimesters are associated with mental health and adverse pregnancy outcomes
2024 · BMC Women s Health · 8 citations
https://doi.org/10.1186/s12905-024-03126-8
Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: long-term results from a single center in China
2015 · BMC Cancer · 5 citations
https://doi.org/10.1186/s12885-015-1534-0
TOSO interacts with SYK and enhances BCR pathway activation in chronic lymphocytic leukemia
2020 · Chinese Medical Journal · 5 citations
https://doi.org/10.1097/cm9.0000000000000999
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat